SV LIFE Sciences FUND IV Strategic Partners, L. P., 10% Owner at OCULAR THERAPEUTIX, INC (OCUL), sold 746,000 shares at $22.00 ($16.4M) on 2015-06-10, disclosed to the SEC on 2015-06-11.
Open-market sale of $16.4M OCUL by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 10,297 | $227K | 1.4% |
| 2 | $22.00 | 362,703 | $8.0M | 48.6% |
| 3 | $22.00 | 373,000 | $8.2M | 50.0% |
| Total | $22.00 avg | 746,000 | $16.4M | 100% |
| Filing → |
| KALV | SELL | 2019-02-21 | $8.8M | — | Filing → |
| OPHT | SELL | 2014-06-05 | $55.8M | — | Filing → |
| TRXC | BUY | 2014-04-23 | $3.0M | — | Filing → |